<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Sokol-Borrelli SL</submitter><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of General Medical Sciences</funding><funding>NIAID NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases</funding><funding>NINDS NIH HHS</funding><funding>NIGMS NIH HHS</funding><funding>U.S. Department of Health &amp;amp; Human Services | NIH | Eunice Kennedy Shriver National Institute of Child Health and Human Development</funding><pagination>6078</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10539341</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>14(1)</volume><pubmed_abstract>Identification of regulators of Toxoplasma gondii bradyzoite development and cyst formation is the most direct way to address the importance of parasite development in long-term persistence and reactivation of this parasite. Here we show that a T. gondii gene (named Regulator of Cystogenesis 1; ROCY1) is sufficient for T. gondii bradyzoite formation in vitro and in vivo. ROCY1 encodes an RNA binding protein that has a preference for 3' regulatory regions of hundreds of T. gondii transcripts, and its RNA-binding domains are required to mediate bradyzoite development. Female mice infected with ΔROCY1 parasites have reduced (>90%) cyst burden. While viable parasites can be cultivated from brain tissue for up to 6 months post-infection, chronic brain-resident ΔROCY1 parasites have reduced oral</pubmed_abstract><journal>Nature communications</journal><pubmed_title>A transcriptional network required for bradyzoite development in Toxoplasma gondii is dispensable for recrudescent disease.</pubmed_title><pmcid>PMC10539341</pmcid><funding_grant_id>F31 AI167594</funding_grant_id><funding_grant_id>R01AI120846</funding_grant_id><funding_grant_id>R01AI116855</funding_grant_id><funding_grant_id>T32 GM133353</funding_grant_id><funding_grant_id>F31NS118865</funding_grant_id><funding_grant_id>R21 AI167662</funding_grant_id><funding_grant_id>R01AI124723</funding_grant_id><funding_grant_id>F31 NS118865</funding_grant_id><funding_grant_id>R01 AI120846</funding_grant_id><funding_grant_id>F31AI167594</funding_grant_id><funding_grant_id>R21AI167662</funding_grant_id><funding_grant_id>F31 AI140529</funding_grant_id><funding_grant_id>R01 AI124723</funding_grant_id><funding_grant_id>R01 AI116855</funding_grant_id><funding_grant_id>T32GM133353</funding_grant_id><funding_grant_id>F31AI140529</funding_grant_id><funding_grant_id>P20 GM125498</funding_grant_id><pubmed_authors>Cabo LF</pubmed_authors><pubmed_authors>Lodoen MB</pubmed_authors><pubmed_authors>Sullivan WJ</pubmed_authors><pubmed_authors>Holmes MJ</pubmed_authors><pubmed_authors>Reilly SM</pubmed_authors><pubmed_authors>Alrubaye HS</pubmed_authors><pubmed_authors>Sokol-Borrelli SL</pubmed_authors><pubmed_authors>Boyle JP</pubmed_authors><pubmed_authors>Sharp KG</pubmed_authors><pubmed_authors>Martorelli Di Genova B</pubmed_authors><pubmed_authors>Orchanian SB</pubmed_authors><pubmed_authors>Massmann MD</pubmed_authors></additional><is_claimable>false</is_claimable><name>A transcriptional network required for bradyzoite development in Toxoplasma gondii is dispensable for recrudescent disease.</name><description>Identification of regulators of Toxoplasma gondii bradyzoite development and cyst formation is the most direct way to address the importance of parasite development in long-term persistence and reactivation of this parasite. Here we show that a T. gondii gene (named Regulator of Cystogenesis 1; ROCY1) is sufficient for T. gondii bradyzoite formation in vitro and in vivo. ROCY1 encodes an RNA binding protein that has a preference for 3' regulatory regions of hundreds of T. gondii transcripts, and its RNA-binding domains are required to mediate bradyzoite development. Female mice infected with ΔROCY1 parasites have reduced (>90%) cyst burden. While viable parasites can be cultivated from brain tissue for up to 6 months post-infection, chronic brain-resident ΔROCY1 parasites have reduced oral</description><dates><release>2023-01-01T00:00:00Z</release><publication>2023 Sep</publication><modification>2026-07-14T18:49:36.826Z</modification><creation>2025-04-04T08:24:11.227Z</creation></dates><accession>S-EPMC10539341</accession><cross_references><pubmed>37770433</pubmed><doi>10.1038/s41467-023-40948-w</doi></cross_references></HashMap>